Group 1 - Shanghai Biling Biotechnology Co., Ltd. recently completed a Series B financing round, raising over 200 million RMB [1] - The financing was led by several investment institutions including Hongcheng Investment, Sunshine Nuohuo, Hongyao Science and Technology Innovation, and others [1] - The company was established in 2021 and is primarily engaged in research and experimental development [1] Group 2 - The registered capital of Shanghai Biling Biotechnology Co., Ltd. is 4.045128 million RMB [1] - The company holds 15 trademark registrations and 14 patents, along with 3 administrative licenses [1] - The shareholders of the company include Shanghai Yikang Phase II Equity Investment Partnership, Hangzhou Huiding Tianzeng Investment Partnership, and others [1]
上海弼领生物技术有限公司获“B轮”融资，金额超2亿人民币
Sou Hu Cai Jing·2026-01-28 06:02